DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Omigapil
Omigapil
Synthesis and Evaluation of Chromone Derivatives As Inhibitors of Monoamine Oxidase
Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A And
Recent Research Developments in Parkinson's Disease
Table of Contents
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
TREAT-NMD Newsletter No.34
The Clinical Trial Landscape in Amyotrophic Lateral Sclerosis—Past, Present, and Future
(12) Patent Application Publication (10) Pub. No.: US 2016/0354335 A1 COHEN Et Al
2016 Medicines in Development for Rare Diseases a LIST of ORPHAN DRUGS in the PIPELINE
Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
P2X7 Receptor Antagonism As a Potential Therapy in Amyotrophic Lateral Sclerosis
Orphan Drug Designation List
Neurological Disorders and the Blood-Brain Barrier
(12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al
Txnip and the Gapdh-Siah1 Signalling Pathway in Diabetic Nephropathy
Molecular Effects of Olecular Effects of Idebenone Idebenone
WO 2013/127918 Al 6 September 2013 (06.09.2013) P O P C T
Orphan Drug Designation List
Top View
New Therapeutic Approaches for Treating Parkinson’S Disease
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: the Cincinnati Cohort Biomarker Program (CCBP)
Chlorella Vulgaris Ameliorates Oxidative Stress and Improves the Muscle Regenerative Capacity of Young and Old Sprague-Dawley Rats
Santhera Pharmaceuticals
Customs Tariff - Schedule Xxi - 1
What Is Parkinson's Disease?
Human Neurogenesis Assay: Ramelteon
CALLISTO Phase 1 Clinical Trial What Is CALLISTO?
The Pennsylvania State University
Neurogenesis Via Modulation of the Muscarinic Receptors
ALS) As a Debilitating Condition to Hawaii's Medical Use of Marijuana Program
Ethanol and Acetaminophen Synergistically Induce Hepatic Aggregation and TCH346- Insensitive Nuclear Translocation of GAPDH
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
2018 Medicines in Development for Neurological Disorders a Report on Disorders of the Brain, Spinal Cord and Nerves
UNIVERSITY of CALIFORNIA Los Angeles Analysis
( 12 ) United States Patent
Assessing the Therapeutic Potential of CRISPR/Cas9-Mediated Gene Modulation in Lama2
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016